1. Home
  2. UPLD vs SNTI Comparison

UPLD vs SNTI Comparison

Compare UPLD & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Upland Software Inc.

UPLD

Upland Software Inc.

HOLD

Current Price

$3.34

Market Cap

12.2M

Sector

Technology

ML Signal

HOLD

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

HOLD

Current Price

$0.31

Market Cap

10.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UPLD
SNTI
Founded
2010
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.2M
10.4M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
UPLD
SNTI
Price
$3.34
$0.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$3.75
$8.50
AVG Volume (30 Days)
32.0K
194.8K
Earning Date
05-01-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
63.38
77.31
EPS
N/A
N/A
Revenue
$74,767,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.95
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.95
N/A
52 Week Low
$0.50
$0.29
52 Week High
$6.65
$2.88

Technical Indicators

Market Signals
Indicator
UPLD
SNTI
Relative Strength Index (RSI) 33.99 29.59
Support Level $0.62 N/A
Resistance Level $5.65 $0.40
Average True Range (ATR) 0.36 0.04
MACD -0.16 0.00
Stochastic Oscillator 3.45 7.74

Price Performance

Historical Comparison
UPLD
SNTI

About UPLD Upland Software Inc.

Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels. Geographically, the company has operations in the U.S., United Kingdom and Canada, of which United States derives maximum revenue.

About SNTI Senti Biosciences Inc.

Senti Biosciences Holdings Inc, formerly known as Senti Biosciences Inc, is a clinical-stage biotechnology company developing cell and gene therapies using its gene circuit platform for patients with incurable diseases. Its gene circuits, created from proprietary DNA sequences, are designed to reprogram cells to sense, compute, and respond to cellular environments. Its product candidates are to kill cancer cells, spare healthy cells, increase specificity, and control drug expression. Its candidate, SENTI-202, is a logic-gated off-the-shelf CAR-NK cell therapy for blood cancers, currently in a Phase 1 clinical trial in the United States and Australia for relapsed or refractory hematological malignancies, including Acute Myeloid Leukemia (AML).

Share on Social Networks: